Stock Events

Stock Events

Aethlon Medical 

€0.19
85
-€15.69-98.81% Wednesday 06:14

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-8.61
-5.8
-3
-0.2
Expected EPS
-2.165567
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-21,591.12Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EJU.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cytodyn
CYDY
Mkt Cap343.01M
CytoDyn Inc. focuses on innovative treatments for HIV and cancer, similar to Aethlon's focus on life-threatening diseases, making them direct competitors in the biotech space.
Gilead Sciences
GILD
Mkt Cap173.41B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops drugs for life-threatening illnesses, including viral diseases, which competes with Aethlon's Hemopurifier therapy.
Sorrento Therapeutics
SRNE
Mkt Cap1.76M
Sorrento Therapeutics, Inc. works on developing therapies for cancer, autoimmune, and infectious diseases, directly competing with Aethlon's disease treatment technologies.
Novavax
NVAX
Mkt Cap1.25B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with Aethlon's focus on therapeutic devices for viral diseases.
Moderna
MRNA
Mkt Cap19.51B
Moderna, Inc. specializes in drug discovery and drug development based on messenger RNA, competing in the infectious disease space with Aethlon.
Inovio Pharmaceuticals
INO
Mkt Cap78.07M
Inovio Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of DNA-based immunotherapies, competing with Aethlon's therapeutic technologies.
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
CRISPR Therapeutics AG specializes in gene editing technologies, which could compete with Aethlon's therapeutic approaches in treating diseases at the genetic level.
Novartis
NVS
Mkt Cap297.32B
Novartis AG is a global healthcare company that researches, develops, manufactures, and markets healthcare products, competing across a broad range of therapeutic areas including those targeted by Aethlon.

About

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Show more...
CEO
Employees
15
Country
Germany
ISIN
US00808Y5050
WKN
000A419N8

Listings

MU
DE
EJU1.MU
STU
DE
EJU1.STU
F
DE
EJU1.F
LSE
GB
0A6R.LSE

0 Comments

Share your thoughts

FAQ

What is Aethlon Medical stock price today?▼
The current price of EJU.F is €0.19 EUR — it has decreased by -98.81% in the past 24 hours. Watch Aethlon Medical stock price performance more closely on the chart.
What is Aethlon Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aethlon Medical stocks are traded under the ticker EJU.F.
What is Aethlon Medical revenue for the last year?▼
Aethlon Medical revenue for the last year amounts to 0 EUR.
What is Aethlon Medical net income for the last year?▼
EJU.F net income for the last year is -21,591.12 EUR.
How many employees does Aethlon Medical have?▼
As of April 12, 2026, the company has 15 employees.
In which sector is Aethlon Medical located?▼
Aethlon Medical operates in the Health & Wellness sector.
When did Aethlon Medical complete a stock split?▼
The last stock split for Aethlon Medical was on June 09, 2025 with a ratio of 1:8.